0000000000605697

AUTHOR

Maria Concetta Fornito

showing 2 related works from this author

Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer

2018

Aim The aim of this retrospective multicentre study was to evaluate the clinical and prognostic effect of fluorine-18-fluorodeoxyglucose (18F-FDG)-PET/computed tomography (CT) in the restaging process of pancreatic cancer (PC). Materials and methods Data from patients treated for primary PC, who underwent18F-FDG-PET/CT for suspicious of disease progression, were collected. Accuracy was assessed employing conventional diagnostic procedures, multidisciplinary team case notes, further18F-FDG-PET/CT scans and/or follow-up. Receiver operating characteristic curve and likelihood ratio (LR+/-) analyses were used for completion of accuracy definition. Progression-free survival (PFS) and overall sur…

AdultMalePrognosioverall survival18F-FDG-PET/CTpancreatic cancer030218 nuclear medicine & medical imaging03 medical and health sciencesdisease progression0302 clinical medicineRetrospective StudieFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyPancreatic cancerrestagingHumansMedicineRadiology Nuclear Medicine and imagingProgression-free survivalRetrospective StudiesAgedNeoplasm StagingReceiver operating characteristicbusiness.industryProportional hazards modelHazard ratioPancreatic NeoplasmArea under the curveRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseConfidence intervalPancreatic Neoplasms030220 oncology & carcinogenesisFemalebusinessNuclear medicineprogression-free survivalHumanNuclear Medicine Communications
researchProduct

Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma

2020

Background: Several studies on 18F-FDG-PET/CT have investigated the prognostic role of this imaging modality in different tumors after treatment. Nevertheless, its role in restaging patients with recurrent CM still needs to be defined. Objective: The aim of this retrospective multicenter study was to evaluate the clinical and prognostic impact of 18F-FDG-PET/CT on the restaging process of cutaneous melanoma (CM) after surgery in patients with suspected distant recurrent disease or suspected metastatic progression disease. Materials and Methods: 74 patients surgically treated for CM underwent 18F-FDG-PET/CT for suspected distant recurrent disease or suspected metastatic progression disease.…

PharmacologyPET-CTmedicine.medical_specialtybusiness.industryProportional hazards modelMelanomaArea under the curveHistologyDiseasemedicine.disease030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisCutaneous melanomaMedical imagingmedicineRadiology Nuclear Medicine and imagingRadiologybusinessCurrent Radiopharmaceuticals
researchProduct